Science Corp implants vision chip in Stargardt patient

science corporation, led by ceo max hodak, has implanted its prima vision-restoring chip in a patient with stargardt disease, an inherited eye disease that gradually destroys central vision. the chip, commercially available in europe for patients with geographic atrophy, aims to restore vision by acting as artificial photoreceptors. the patient, part of an ongoing trial at sydney eye hospital, was able to see a letter and read a word during rehabilitation sessions. science corporation plans to develop its brain-computer interface technology, with potential applications in various medical conditions.